BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11845612)

  • 21. Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
    Chew R; Woods ML
    Am J Trop Med Hyg; 2021 Oct; 106(2):373-375. PubMed ID: 34695791
    [No Abstract]   [Full Text] [Related]  

  • 22. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined therapy in leprosy.
    Gatti JC
    Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
    [No Abstract]   [Full Text] [Related]  

  • 24. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histoid leprosy].
    Tirhazouine I; Chiheb S; Hali F; Rifki A; Benchikhi H
    Ann Dermatol Venereol; 2013 Mar; 140(3):244-5. PubMed ID: 23466165
    [No Abstract]   [Full Text] [Related]  

  • 26. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous occurrence of upgrading and downgrading type 1 (lepra) reaction.
    Sehgal VN; Bhattacharya SN; Sharma VK; Mathur RP
    Int J Dermatol; 1990 Jun; 29(5):356-7. PubMed ID: 2361792
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined chemotherapy of multibacillary leprosy of 6 months' duration.
    Onsun N; Saylan T; Pattyn SR
    Lepr Rev; 1986; 57 Suppl 3():124-6. PubMed ID: 3573952
    [No Abstract]   [Full Text] [Related]  

  • 29. [Borderline lepromatous leprosy].
    El Morabite K; Tbatou F; Ait Ourhroui M; Senouci K; Hassam B
    Presse Med; 2014 Jun; 43(6 Pt 1):733-4. PubMed ID: 24703733
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombocytopenic purpura with blood blisters on once a month rifampicin.
    Selwyn GJ; Jayakumar A; Samson PD
    Indian J Lepr; 1996; 68(4):371-2. PubMed ID: 9001906
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combination chemotherapy in leprosy].
    Leiker DL
    Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1926-9. PubMed ID: 3774040
    [No Abstract]   [Full Text] [Related]  

  • 32. Leprosy. Recognition and treatment.
    Ramos-e-Silva M; Rebello PF
    Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Hansen's disease.
    Alto WA
    Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal hypersensitivity vasculitis associated with dapsone.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
    Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
    Manga NM; Poda A; Bazolo N; Sané O; Batista G; Guèye NF; Sow PS; Badiane CI
    Med Mal Infect; 2011 Jul; 41(7):390-1. PubMed ID: 21458936
    [No Abstract]   [Full Text] [Related]  

  • 36. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.
    Al-Raqum HA; Uppal SS; El Abdalghani RA; Lasheen I
    Clin Rheumatol; 2006 Feb; 25(1):101-5. PubMed ID: 16247582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.